In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).
CHPA is committed to advancing solutions to illegal sales that penalize criminals and ensure law-abiding consumers continue to have access to a wide range of treatment options, including nonprescription medicines containing PSE.
On Tuesday, April 13, the Oregon House Committee on Health Care voted unanimously to advance H.B. 2648 to the full House of Representatives for a vote.
This week, the House Energy and Commerce Health Subcommittee is holding a hearing, entitled: "An Epidemic within a Pandemic: Understanding Substance Use and Misuse in America."
On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing a law that overturns the state’s ban of over-the-counter (OTC) sales of pseudoephedrine (PSE).
On Tuesday, March 9, the Mississippi House voted to repeal the state’s existing ban of over-the-counter (OTC) sales of pseudoephedrine (PSE) on an 117-3 vote. Since 2010, Mississippi has categorized PSE as a schedule III controlled substance.
